Dennis Slamon - 18 Mar 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Reporting relationship
Director
Issuer ticker
BMRN
Reported as of
18 Mar 2024
Net transaction value
-$33.1
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Mar 2024, 17:13:32 UTC
Prior SEC filing
24 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tae Sang Yoo, Attorney-in-Fact

Key filing fact

Dennis Slamon filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 20 Mar 2024.

Key facts

  • This page summarizes Dennis Slamon's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Mar 2024, 17:13.

Change

  • Previous filing in this sequence was filed on 24 May 2023.
  • Current net transaction value: -$33.1.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRN transaction

Common Stock

Options Exercise

Transaction value
$797,000
Shares
+10,000
Change %
+32%
Price
$79.70
Shares after
40,809
Date
18 Mar 2024
Ownership
Direct
BMRN transaction

Common Stock

Tax liability

Transaction value
$797,033
Shares
-9,510
Change %
-23%
Price
$83.81
Shares after
31,299
Date
18 Mar 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMRN transaction Derivative

Stock Option (Right to Buy Common Stock)

Options Exercise

Transaction value
$0
Shares
-10,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
18 Mar 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$79.70
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the number of options outstanding after the transaction from this specific stock option grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .